Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on July 15, 2025

Enkrypt AI Releases Groundbreaking CBRN Red Teaming Study, Uncovering Major Safety Gaps in Frontier AI Models
First-of-its-kind report reveals critical vulnerabilities in AI safety systems, posing global security concerns BOSTON, MA, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- Enkrypt AI Releases Groundbreaking CBRN Red Teaming Study, Uncovering Major …

Eventus Scientifica Establishes Scientific Advisory Board to Support Rapid Growth and Expanded Services
MYRTLE BEACH, SC, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- Eventus Scientifica LLC, a fast-growing consulting firm specializing in scientific and high-technology markets, proudly announces the formation of its Scientific Advisory Board. This …

Bogus Experts Fuel Mould Epidemic
Mould Illness Is Becoming an Uncontrollable …

ExecutiveRehabs.com Announces its Redesigned Platform With Vetted Recovery Support for Working Professionals
Newly relaunched ExecutiveRehabs.com helps professionals find discreet, insurance-covered addiction treatment with expert support and California options. DELRAY BEACH, FL, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- ExecutiveRehabs.com, a 20-year …

RouteGenie Launches New Review Generation Module to Help NEMT Providers Grow Online Reputation
RouteGenie launches a new Customer Relationship + Review Generation Module to help NEMT providers build rider loyalty and boost online reviews—automatically. BUFFALO, NY, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- RouteGenie, the leading …

Synametrics Technologies has released a new version of Xeams - Version 9.8 Build 6381
New in Xeams 9.8: Launch email campaigns, track delivery events in real time, monitor failures, and configure multiple smart hosts with ease. MILLSTONE, NJ, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- Synametrics Technologies Inc., a trusted …

AvenioGPT Alpha Launch Sparks High Demand Across BioPharma and Research Entities
Building the Palantir for BioPharma: Avenio Debuts AvenioGPT to Enhance Clinical Research …

Cincinnati Rehabilitation Hospital at Blue Ash Announces New CEO
Mark Dwyer, MHA, PT, FACHE, Appointed Chief Executive Officer BLUE ASH, OK, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- Mark Dwyer brings over 30 years of leadership expertise in medical rehabilitation services across healthcare systems and …

Mitch Gould and NPI Set to Attend ECRM’s September 2025 Vitamin, Weight Management & Sports Nutrition Session
BOCA RATON, FL, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- Mitch Gould, founder and CEO of Nutritional Products International (NPI), will once again bring his team to the forefront of retail innovation at the upcoming ECRM Vitamin, Weight …

Techcyte Welcomes Industry Veterans Amy DuRoss and Karine Sellam as New Board Members
OREM, UT, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, is pleased to announce the appointment of two new members to its Board of Directors: Amy …

bonyf Reaffirms Its Long-Term Vision Amid Short-Term Market Volatility
bonyf Reaffirms Its Long-Term Vision Amid Short-Term Market Volatility. bonyf Reaffirms Its Long-Term Vision Amid Short-Term Market Volatility KNOKKE-HEIST, KNOKKE-HEIST, BELGIUM, July 15, 2025 /EINPresswire.com/ -- bonyf NV (Mnemonic: MLBON), a leader …

World’s Healthcare Leaders to Return to Riyadh for Global Health Exhibition 2025 in October
Doubling in size, Global Health Exhibition is set to host 20 international pavilions – driving further overseas growth for 2025 RIYADH, SAUDI ARABIA, July 15, 2025 /EINPresswire.com/ -- Under the patronage of the Ministry of Health and supported by …

Biotricity to Host Fiscal 2025 Fourth Quarter Financial Results and Business Update Call on July 18th
Company to announce improvements in Margins, Operational Efficiency, and a shift to positive Adjusted EBITDA REDWOOD CITY, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), an innovative Technology-as-a-Service (TaaS) company …

Aptose Receives Second Advance under the Loan Agreement with Hanmi Pharmaceutical to Continue Development of Tuspetinib in Triplet Therapy for AML
SAN DIEGO and TORONTO, July 15, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat …

Gain Therapeutics Announces Proposed Public Offering
BETHESDA, Md., July 15, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …

ADR Ratio Change
July 15, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) ADR Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company developing a pipeline of innovative products for the …

Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue
AUDUBON, Pa., July 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the expanded Excelsius™ navigation capabilities of its next-generation oscillating system, DuraPro™, as the …

Ikena Oncology Announces Stockholder Approval of Merger with Inmagene Biopharmaceuticals
Combined Company to Trade on Nasdaq Under Ticker “IMA” Ikena Announces 1-for-12 Reverse Stock Split of Ikena Common Stock BOSTON and SAN DIEGO, July 15, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA) (“Ikena”) today announced the results of …

Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025
SEATTLE, July 15, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, …

Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LONDON …